| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ChemoCentryx, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 5.19M | $265M | $50.95 | 12 Oct 2021 | Indirect |
| Cara Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 7.4M | $9.02M | $1.22 | 20 Oct 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CARA | Cara Therapeutics, Inc. | 20 Oct 2021 | 0 | $0 | 3 | 10%+ Owner | 21 Oct 2021, 16:30 |
| CCXI | ChemoCentryx, Inc. | 12 Oct 2021 | 1 | -$158M | 4 | 10%+ Owner | 13 Oct 2021, 19:05 |